Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-07-11
2006-07-11
Fay, Zohreh (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S903000
Reexamination Certificate
active
07074827
ABSTRACT:
Provided is a method for treating ocular hypertension and glaucoma with reduced side effects such as keratoconjunctive disorders and macular edema, which comprises administering an ophthalmic composition comprising latanoprost as an active ingredient thereof to a subject in need of said treatment, wherein the ophthalmic composition contains substantially no benzalkonium chloride.
REFERENCES:
patent: 2002/0103255 (2002-08-01), Hellberg et al.
patent: 2003/0018079 (2003-01-01), Richardson et al.
patent: WO 01/95913 (2001-12-01), None
patent: WO 02/38158 (2002-05-01), None
patent: WO 2004/022063 (2004-03-01), None
Costagliola, Ciro, et al., “Ocular surface changes induced by topical application of latanoprost and timolol: a short-term study in glaucomatous patients with and without allergic conjunctivitis” Graefe's Arch Clin Exp Ophthalmol (2001), 239: pp. 809-814. XP-002272140.
Noda, Eiichiro, et al., “Blood-aqueous barrier disruption and increment of cystoid macular edema incidence detected by fluorescent angiography caused by ophthalmic solution containing timololol and a preservative thereof in early postoperative pseudophakes”, Th 105thAnnual Meeting of the Japanese Ophthalmology Society, Apr. 19-21, 2001, Place: Pacifico Yokohana.
Xalatan, Pharmacia & Upjohn (4 pages), revised Nov. 2000.
International Search Report.
Fay Zohreh
Sucampo AG (USA) Inc.
LandOfFree
Method for treating ocular hypertension and glaucoma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating ocular hypertension and glaucoma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating ocular hypertension and glaucoma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3549539